fingolimod hydrochloride has been researched along with Asymptomatic Colonization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldanti, F; Bergamaschi, R; Fabbro, BD; Franciotta, D; Gastaldi, M; Mallucci, G; Zito, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and Asymptomatic Colonization
| Article | Year |
|---|---|
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.
Topics: Adult; Antibodies, Viral; Asymptomatic Infections; COVID-19; Female; Fingolimod Hydrochloride; Humans; Male; Middle Aged; Multiple Sclerosis; Natalizumab; RNA, Viral; SARS-CoV-2; Seroepidemiologic Studies | 2021 |